Measures of medication adherence to noninsulin diabetes medications (NIDM), statins, and renin angiotensin system antagonists (RASA) have been continuously used in the star ratings program since 2012. Adherence to these treatments is undoubtedly important. However, the consistent use of these measures in the star ratings program over time has limitations.
AMCP CEO Blog: This truism lies at the heart of much of what managed care pharmacy does. AMCP members and their organizations have long championed the use of preventive-care services to achieve better health outcomes and lower overall health care costs.
AMCP webinar that detailed the state of the performance measurement landscape, profiles how quality impacts team-based models of care, the Enhanced MTM program, and others, and describes why this impact matters in managed care.
Partnership Forum: The event brought industry leaders to together in November 2016, focused on the need to drive better value and outcomes in oncology for patients, providers, payers and delivery networks.